These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3482108)

  • 1. Prolongation of life span of dystrophic hamster by cysteine proteinase inhibitor, loxistation (EST).
    Tamai M; Omura S; Kimura M; Hanada K; Sugita H
    J Pharmacobiodyn; 1987 Nov; 10(11):678-81. PubMed ID: 3482108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a cysteine protease inhibitor EST on urinary 3-methylhistidine in dystrophic hamsters (BIO 14.6)].
    Terao T; Mashino K; Takatsu M; Hiraguchi M
    Rinsho Shinkeigaku; 1986 Nov; 26(11):1218-23. PubMed ID: 3549099
    [No Abstract]   [Full Text] [Related]  

  • 3. The disposition of loxistatin and metabolites in normal and dystrophic hamsters.
    Fukushima K; Kohno Y; Osabe W; Suwa T; Satoh T
    Xenobiotica; 1991 Jan; 21(1):23-31. PubMed ID: 2003364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic trials on progressive muscular dystrophy.
    Satoyoshi E
    Intern Med; 1992 Jul; 31(7):841-6. PubMed ID: 1450492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64.
    Tamai M; Matsumoto K; Omura S; Koyama I; Ozawa Y; Hanada K
    J Pharmacobiodyn; 1986 Aug; 9(8):672-7. PubMed ID: 3023601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited benefit to genetically dystrophic chickens from a synthetic proteinase inhibitor: Ep475.
    Hudecki MS; Pollina CM; Heffner RR
    J Neurol Sci; 1983 Jul; 60(1):55-66. PubMed ID: 6875613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic mice.
    Komatsu K; Inazuki K; Hosoya J; Satoh S
    Exp Neurol; 1986 Jan; 91(1):23-9. PubMed ID: 3940877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases in cathepsins B and L and thiol proteinase inhibitor in muscle of dystrophic hamsters. Their localization in invading phagocytes.
    Kominami E; Bando Y; Ii K; Hizawa K; Katunuma N
    J Biochem; 1984 Dec; 96(6):1841-8. PubMed ID: 6530400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmodulin levels in developing muscle tissues and primary cultures of normal and dystrophic (UM-X7.1) hamsters.
    Klamut HJ; Kotarba JA; Strickland KP
    Muscle Nerve; 1987 Jan; 10(1):69-76. PubMed ID: 3561440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid ablation in dystrophic hamsters. Effects on Ca content and histology of heart, diaphragm, and rectus femoris.
    Palmieri GM; Nutting DF; Bhattacharya SK; Bertorini TE; Williams JC
    J Clin Invest; 1981 Sep; 68(3):646-54. PubMed ID: 7276164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial of a cysteine proteinase inhibitor, EST, in experimental chloroquine myopathy in rats.
    Sugita H; Higuchi I; Sano M; Ishiura S
    Muscle Nerve; 1987; 10(6):516-23. PubMed ID: 3306368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of diltiazem in dystrophic hamsters.
    Bhattacharya SK; Palmieri GM; Bertorini TE; Nutting DF
    Muscle Nerve; 1982 Jan; 5(1):73-8. PubMed ID: 7057811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental animal information file: effect of bestatin in muscular dystrophy in mice].
    Kawamata J
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2425-6. PubMed ID: 6639104
    [No Abstract]   [Full Text] [Related]  

  • 14. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase in normal and dystrophic hamsters.
    Greenough MC; Boegman RJ
    Biochem J; 1982 Mar; 201(3):501-4. PubMed ID: 7201315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin content and Ca-activated protease activity in dystrophic hamster muscles.
    Klamut HJ; Lin CH; Strickland KP
    Muscle Nerve; 1983; 6(6):436-41. PubMed ID: 6312308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of thyroxine treatment on diaphragm and EDL of normal and dystrophic hamsters.
    Singh YN; Schlenker EH; Singh BN; Burbach JA
    Can J Physiol Pharmacol; 2004 May; 82(5):345-52. PubMed ID: 15213735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the ultrastructure of primary cultures of normal and dystrophic hamster tongue muscle.
    Thakar JH; Thede A; Strickland KP
    Muscle Nerve; 1980; 3(4):340-4. PubMed ID: 7412777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance of normal and dystrophic hamsters to d-tubocurarine.
    Bokdawala F; Jasmin G
    Rev Can Biol; 1969 Dec; 28(4):267-9. PubMed ID: 5369452
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of murine muscular dystrophy with the protease inhibitor bestatin.
    Tsuji S; Matsushita H
    J Neurol Sci; 1986 Feb; 72(2-3):183-94. PubMed ID: 3711932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An endogenous inhibitor of calcium-activated neutral protease in UMX 7.1 hamster dystrophy.
    Nakamura M; Imajoh-Ohmi S; Suzuki K; Kawashima S
    Muscle Nerve; 1991 Aug; 14(8):701-8. PubMed ID: 1890994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.